Statistics

Total Visits

Views
CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP111

Select a period of time:

Number of views in the range

Views
CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP62

Views

Views
November 20254
December 20254
January 202611
February 20262
March 202622
April 202613
May 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States36
Mexico3
France3
United Kingdom2
Turkey2
South Africa2
Brazil2
Argentina1
Australia1
Bangladesh1
 

Top cities views

Views
San Jose12
Ashburn5
Acapulco de Juárez1
Amsterdam1
Ankara1
Atlanta1
Centurion1
Chennai1
Cumming1
Edinburgh1